We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+10.96%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$771B
AUM Growth
+$65B
Cap. Flow
+$3.26B
Cap. Flow %
0.42%
Top 10 Hldgs %
21.76%
Holding
2,605
New
87
Increased
1,561
Reduced
802
Closed
81

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$6.97B
2
AMD icon
Advanced Micro Devices
AMD
+$1.37B
3
LULU icon
lululemon athletica
LULU
+$1.32B
4
SPOT icon
Spotify
SPOT
+$1.28B
5
NOW icon
ServiceNow
NOW
+$1.25B

Top Sells

Rank Stock Value
1
BA icon
Boeing
BA
+$3.41B
2
NOC icon
Northrop Grumman
NOC
+$2.36B
3
MSFT icon
Microsoft
MSFT
+$2.2B
4
MCD icon
McDonald's
MCD
+$1.85B
5
ICE icon
Intercontinental Exchange
ICE
+$1.28B

Sector Composition

Rank Sector Weight
1 Technology 21.34%
2 Healthcare 16.78%
3 Financials 13.77%
4 Consumer Discretionary 12.98%
5 Communication Services 10.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YMAB
2551
DELISTED
Y-mAbs Therapeutics
YMAB
-837,800
Closed -$21.8M
ZEPP
2552
Zepp Health
ZEPP
$79.9M
-23,417
Closed -$937K
CMRX
2553
DELISTED
Chimerix, Inc.
CMRX
-21,121
Closed -$50K
KA
2554
DELISTED
Kineta, Inc. Common Stock
KA
-321
Closed -$38K
ASXC
2555
DELISTED
Asensus Surgical, Inc.
ASXC
-11,476
Closed -$92K
IMGN
2556
DELISTED
Immunogen Inc
IMGN
-1,010,498
Closed -$2.44M
LOV
2557
DELISTED
Spark Networks SE American Depositary Shares
LOV
-144,981
Closed -$802K
MNTV
2558
DELISTED
Momentive Global Inc. Common Stock
MNTV
-69,262
Closed -$1.18M
MYOV
2559
DELISTED
Myovant Sciences Ltd.
MYOV
-613,315
Closed -$3.19M
EXTN
2560
DELISTED
Exterran Corporation
EXTN
-373,120
Closed -$4.87M
IRCP
2561
DELISTED
IRSA Propiedades Comerciales S.A.
IRCP
-294,190
Closed -$866K
XEC
2562
CALL
DELISTED
CIMAREX ENERGY CO
XEC
-3,500
Closed -$168K
IFFT
2563
DELISTED
International Flavors & Fragrances Inc. 6.00% Tangible Equity Units
IFFT
-392,042
Closed -$18.5M
HCR
2564
DELISTED
Hi-Crush Inc. Common Stock
HCR
-52,974
Closed -$92K
STML
2565
DELISTED
Stemline Therapeutics, Inc.
STML
-176,795
Closed -$1.84M
CISN
2566
DELISTED
Cision Ltd. Ordinary Share
CISN
-2,549,802
Closed -$19.6M
ARQL
2567
DELISTED
Arqule Inc
ARQL
-432,833
Closed -$3.1M
BOLD
2568
DELISTED
Audentes Therapeutics, Inc
BOLD
-394,539
Closed -$11.1M
AVP
2569
DELISTED
Avon Products, Inc.
AVP
-252,300
Closed -$1.11M
SMTA
2570
DELISTED
Spirit MTA REIT Common Shares of Beneficial Interest
SMTA
-49,480
Closed -$418K
GWR
2571
DELISTED
Genesee & Wyoming Inc.
GWR
-267,255
Closed -$29.5M
LKSD
2572
DELISTED
LSC Communications, Inc.
LKSD
-12,114
Closed -$17K
CRZO
2573
DELISTED
Carrizo Oil & Gas Inc
CRZO
-48,577
Closed -$417K
CRR
2574
DELISTED
Carbo Ceramics Inc.
CRR
-43,700
Closed -$105K
HOS
2575
DELISTED
Hornbeck Offshore Services, Inc.
HOS
-31,800
Closed -$24K

Similar funds

T. Rowe Price Associates's Q4 2019 Portfolio in Review

As of Q4 2019, T. Rowe Price Associates held 2,605 positions worth $771B, up 9.2% from $706B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

T. Rowe Price Associates's Q4 2019 filing shows 87 new, 1,561 increased, 802 reduced and 81 closed positions. Its largest new stake was XP: 7,905,172 shares worth $305M. The largest sale was Boeing, an estimated $3.41B.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q4 2019 buy was XP: 7,905,172 shares worth $305M.
  • T. Rowe Price Associates added most to Apple in Q4 2019, an estimated $6.97B increase.
  • T. Rowe Price Associates's biggest Q4 2019 reduction was Boeing, cutting an estimated $3.41B.
  • T. Rowe Price Associates fully exited Viacom Inc. Class B in Q4 2019, selling an estimated $204M.
  • T. Rowe Price Associates's ten largest holdings make up 22% of its $771B portfolio in Q4 2019.
  • T. Rowe Price Associates opened 87 new positions and closed 81 in Q4 2019.
  • T. Rowe Price Associates's portfolio value rose 9.2% quarter-over-quarter to $771B.

Based on T. Rowe Price Associates's 13F filing for Q4 2019, filed 14 Feb 2020.